Sinco Pharmaceuticals Holdings Limited (6833.HK)
HKD 0.18
(-6.91%)
HKD 0.18
(-6.91%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.54 Billion | 2.27 Billion | 2.02 Billion | 2.04 Billion | 1.17 Billion | 952.95 Million |
| Cost of Revenue | 2.21 Billion | 1.96 Billion | 1.65 Billion | 1.77 Billion | 956.56 Million | 849.8 Million |
| Gross Profit | 323.28 Million | 305.86 Million | 364.95 Million | 273.82 Million | 219.84 Million | 103.15 Million |
| Operating Expenses | 215.11 Million | 195.18 Million | 177.43 Million | 132.95 Million | 157.17 Million | 340.97 Million |
| Selling, General and Administrative Expenses | 206.82 Million | 204.64 Million | 172.39 Million | 130.03 Million | 161.66 Million | 325.02 Million |
| Research and Development Expenses | 8.29 Million | 11.27 Million | 26.16 Million | 812 Thousand | 1.58 Million | 2.07 Million |
| Other Expenses | - | 311 Thousand | 1.36 Million | -3.81 Million | -6.17 Million | -121.03 Million |
| Cost and Expenses | 2.43 Billion | 2.16 Billion | 1.83 Billion | 1.9 Billion | 1.11 Billion | 1.19 Billion |
| Operating Income | 108.16 Million | 101.22 Million | 192.55 Million | 143.78 Million | 58.18 Million | -217.01 Million |
| Interest Expense | 9.8 Million | 13.81 Million | 28.02 Million | 8.79 Million | 20.02 Million | 34.81 Million |
| Income Tax Expense | 57.52 Million | 29.83 Million | 32.3 Million | 17.81 Million | 19.4 Million | 8.6 Million |
| Earnings before Tax | 99.88 Million | 99.29 Million | 167.38 Million | 135.95 Million | 42.95 Million | -272.01 Million |
| Net Income | 42.35 Million | 69.46 Million | 135.08 Million | 118.13 Million | 22.89 Million | -280.61 Million |
| Earnings Per Share Basic | 0.02 | 0.03 | 0.08 | 0.07 | 0.01 | -0.17 |
| Earnings Per Share Diluted | 0.02 | 0.03 | 0.08 | 0.07 | 0.01 | -0.17 |
| Weighted Average Shares Outstanding | 2.03 Billion | 2.03 Billion | 1.73 Billion | 1.69 Billion | 1.69 Billion | 1.68 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.03 Billion | 2.03 Billion | 1.73 Billion | 1.69 Billion | 1.69 Billion | 1.68 Billion |
| Gross Margin | 0.13 | 0.13 | 0.18 | 0.13 | 0.19 | 0.11 |
| EBIT Margin | 0.05 | 0.05 | 0.10 | 0.07 | 0.06 | -0.22 |
| Profit Margin | 0.02 | 0.03 | 0.07 | 0.06 | 0.02 | -0.29 |
| EBITDA | 126 Million | 109.01 Million | 197.69 Million | 152.04 Million | 67.5 Million | -206.64 Million |
| Earnings Before Tax Margin | 0.04 | 0.04 | 0.10 | 0.07 | 0.05 | -0.23 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 1.52 Billion | 2.54 Billion | 1.44 Billion | 1.09 Billion | 2.27 Billion | 1.14 Billion |
| Cost of Revenue | 1.35 Billion | 2.21 Billion | 1.27 Billion | 937.58 Million | 1.96 Billion | 1.02 Billion |
| Gross Profit | 173.21 Million | 323.28 Million | 170.73 Million | 152.54 Million | 305.86 Million | 113.67 Million |
| Operating Expenses | 115.28 Million | 205.5 Million | 120.93 Million | 106.14 Million | 195.18 Million | 90.45 Million |
| Selling, General and Administrative Expenses | 101.88 Million | - | 114.14 Million | 92.67 Million | - | 93.39 Million |
| Research and Development Expenses | 13.4 Million | - | 6.79 Million | 1.5 Million | - | 11.27 Million |
| Other Expenses | - | -6.46 Million | - | - | 311 Thousand | - |
| Cost and Expenses | 1.46 Billion | 2.42 Billion | 1.4 Billion | 1.04 Billion | 2.16 Billion | 1.11 Billion |
| Operating Income | 57.92 Million | 116.46 Million | 49.79 Million | 56.27 Million | 101.22 Million | 20.27 Million |
| Interest Expense | - | 9.8 Million | - | - | 13.81 Million | - |
| Income Tax Expense | 44.12 Million | 57.52 Million | 34.35 Million | 23.17 Million | 29.83 Million | 13.18 Million |
| Earnings before Tax | 67.99 Million | 99.88 Million | 57.11 Million | 42.76 Million | 99.29 Million | 20.72 Million |
| Net Income | 23.87 Million | 42.35 Million | 22.75 Million | 19.59 Million | 69.46 Million | 7.53 Million |
| Earnings Per Share Basic | 0.01 | - | 0.01 | 0.01 | - | 0.00 |
| Earnings Per Share Diluted | 0.01 | - | 0.01 | 0.01 | - | 0.00 |
| Weighted Average Shares Outstanding | 2.03 Billion | 2.03 Billion | 2.03 Billion | 2.03 Billion | 2.03 Billion | 2.14 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.03 Billion | 2.03 Billion | 2.03 Billion | 2.03 Billion | 2.03 Billion | 2.03 Billion |
| Gross Margin | 0.11 | 0.13 | 0.12 | 0.14 | 0.13 | 0.10 |
| EBIT Margin | 0.05 | - | 0.05 | 0.06 | - | 0.02 |
| Profit Margin | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.01 |
| EBITDA | 78.61 Million | - | 65.98 Million | 61.36 Million | - | 24.68 Million |
| Earnings Before Tax Margin | 0.04 | 0.05 | 0.03 | 0.05 | 0.04 | 0.02 |
7635
690D
5530
600255
PLAY
XTEPY